| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-2952(92)90044-J |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:000629529290044J?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:000629529290044J?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1632825 |
| P2093 | author name string | J. D. Gralla | |
| G. L. Evans | |||
| P2860 | cites work | Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 |
| Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
| Nuclease hypersensitive sites in chromatin | Q34164152 | ||
| Drugs five years later. Cisplatin | Q34257493 | ||
| Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas | Q35614985 | ||
| 5' flanking and first intron sequences of the human beta-actin gene required for efficient promoter activity | Q35861061 | ||
| Cis and trans activation of adenovirus IVa2 gene transcription | Q36144119 | ||
| Sequences upstream from the T-A-T-A box are required in vivo and in vitro for efficient transcription from the adenovirus serotype 2 major late promoter | Q36322310 | ||
| c-Ha-ras gene bidirectional promoter expressed in vitro: location and regulation | Q36760158 | ||
| Structure and Expression of the Oncogene c-myc in Fresh Tumor Material from Patients with Hematopoietic Malignancies | Q36945187 | ||
| Gene Transfer: DNA Microinjection Compared with DNA Transfection with a Very High Efficiency | Q36975184 | ||
| Proximal and distal domains that control in vitro transcription of the adenovirus IVa2 gene | Q37572403 | ||
| Requirement of host cell RNA polymerase II in the replication of herpes simplex virus in α-amanitin sensitive and -resistant cell lines | Q40044600 | ||
| Upstream regulatory regions required to stabilize binding to the TATA sequence in an adenovirus early promoter | Q40391090 | ||
| Functional analysis of the transcription control region located within the avian retroviral long terminal repeat | Q40665817 | ||
| Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia | Q41714603 | ||
| Cisplatin resistance and mechanism in a viral test system: SV40 isolates that resist inhibition by the antitumor drug have lost regulatory DNA. | Q41737449 | ||
| Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. | Q42735234 | ||
| DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. | Q44072665 | ||
| Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro | Q44552882 | ||
| Multiple Point Mutations Affecting the Simian Virus 40 Enhancer | Q45799028 | ||
| Cisplatin-induced imbalances in the pattern of chimeric marker gene expression in HeLa cells | Q46561743 | ||
| Interactions between mammalian cell DNA and inorganic platinum compounds. II. Interstrand cross-linking of isolated and cellular DNA by platinum(IV) compounds | Q47866082 | ||
| Binding of the Sp1 transcription factor by the human Harvey ras1 proto-oncogene promoter | Q48363916 | ||
| Promoter region of the human Harvey ras proto-oncogene: similarity to the EGF receptor proto-oncogene promoter. | Q48372152 | ||
| Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. | Q53530420 | ||
| The effect of monofunctional or difunctional platinum adducts and of various other associated DNA damage on the expression of transfected DNA in mammalian cell lines sensitive or resistant to difunctional agents. | Q54408271 | ||
| Structural aspects of platinum anticancer drug interactions with DNA | Q60174164 | ||
| Induction of fos RNA by DNA-damaging agents | Q62746105 | ||
| Analysis of various mRNA potentially involved in cisplatin resistance of murine leukemia L1210 cells | Q68092828 | ||
| Synthesis and 1H NMR spectroscopic characterization of trans-[Pt(NH3)2[d(ApGpGpCpCpT)-N7-A(1),N7-G(3)]] | Q69441288 | ||
| In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication | Q70126283 | ||
| Subcellular localization of cis-dichlorodiammineplatinum(II) in rat kidney and liver | Q70653749 | ||
| Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity | Q70791156 | ||
| Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo | Q71588838 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| pharmacology | Q128406 | ||
| P304 | page(s) | 107-119 | |
| P577 | publication date | 1992-07-01 | |
| 1992-07-07 | |||
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Differential effects of cisplatin on the expression of chimeric marker genes in CV-1 cells | |
| P478 | volume | 44 |
| Q36149816 | Cisplatin damage: are DNA repair proteins saviors or traitors to the cell? |
| Q34566020 | Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo |
| Q37660257 | Host Cell Reactivation and Transcriptional Activation of Carboplatin-Modified BRCA1. |
| Q78045586 | Rapid fluorescence-based reporter-gene assays to evaluate the cytotoxicity and antitumor drug potential of platinum complexes |
| Q37055940 | The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells |
Search more.